Rowena Choudrie
About Rowena Choudrie
Rowena Choudrie is a CMC Team Leader at Bristol Myers Squibb with over 30 years of experience in pharmaceutical development and leadership roles across both large pharmaceutical companies and smaller biotech firms.
Current Role at Bristol Myers Squibb
Rowena Choudrie is currently serving as a CMC Team Leadership at Bristol Myers Squibb based in New Jersey, United States. She joined the company in November 2020. In her role, she focuses on managing Chemistry, Manufacturing, and Controls (CMC) operations, leveraging her extensive experience in pharmaceutical development and leadership.
Previous Leadership Roles in Pharmaceutical Industry
Rowena Choudrie has held several leadership positions in the pharmaceutical industry. She worked at Celgene as Senior Director of Pharmaceutical Sciences & Technology, Compound Leadership from 2017 to 2020. Prior to that, she was the Sr. Director of Pharmaceutical Product Development at Actinium Pharmaceuticals, Inc., during 2016 and 2017. Between 2010 and 2015, she was the Senior Director of Pharmaceutical Development at NPS Pharmaceuticals. She also worked at EBR Life Sciences as CMC Principal from 2009 to 2010.
Experience as an Adjunct Professor
In addition to her industry roles, Rowena Choudrie has academic experience. She worked as an Adjunct Professor at Stevens Institute of Technology from 2009 to 2014. During her tenure at the institute, she focused on Pharmaceutical Manufacturing Engineering, imparting her extensive knowledge in pharmaceutical sciences to students.
Early Career in Pharmaceutical Product Development
Earlier in her career, Rowena Choudrie had significant roles in pharmaceutical product development. She served as Director of Formulation & Manufacturing at Palatin Technologies from 2004 to 2009. This was preceded by a 14-year tenure at Schering-Plough Research Institute, where she held the role of Principal Engineer, Product Devt Team Chair starting in 1990.
Comprehensive Experience in Pharmaceutical Sciences
Over her 30-year career, Rowena Choudrie has amassed extensive experience in pharmaceutical sciences, spanning formulation, manufacturing, and compound leadership. Her background includes leading teams in both large pharmaceutical companies like Schering-Plough and smaller biotech firms such as Palatin Technologies and Actinium Pharmaceuticals. Her diverse roles have endowed her with a deep understanding of the pharmaceutical development lifecycle.